Document:

srcl-ex103_105.htm

Exhibit 10.3

 

 

 

 

 

Stericycle, Inc.

___________________________________

Fourth Amendment

Dated as of December 19, 2018

to

Note Purchase Agreement

Dated as of October 22, 2012

___________________________________

 

Re:2.68% Senior Notes, Series A, due December 12, 2019

and

3.26% Senior Notes, Series B, due December 12, 2022

 

 

 

 

 

Fourth Amendment to Note Purchase Agreement

This Fourth Amendment dated as of December 19, 2018 (this “Agreement”) to the Note Purchase Agreement referred to below is between Stericycle, Inc., a Delaware corporation (the “Company”), and each of the institutions which is a signatory to this Agreement (collectively, the “Noteholders”).

Recitals:

Whereas, the Company and each of the Noteholders have heretofore entered into the Note Purchase Agreement dated as of October 22, 2012, as amended by that certain First Amendment thereto dated as of August 13, 2015, that certain Second Amendment thereto dated as of July 28, 2017 and that certain Third Amendment thereto dated as of March 23, 2018 (as so amended, the “Note Purchase Agreement”), pursuant to which the Company issued on or about December 12, 2012 (a) $125,000,000 aggregate principal amount of its 2.68% Senior Notes, Series A, due December 12, 2019 (as amended, the “Series A Notes”) and (b) $125,000,000 aggregate principal amount of its 3.26% Senior Notes, Series B, due December 12, 2022 (as amended, the “Series B Notes” and together with the Series A Notes, collectively, the “Notes”);

Whereas, the Company and the Noteholders now desire to amend the Note Purchase Agreement and the Notes in the respects, but only in the respects, hereinafter set forth;

Whereas, all capitalized terms used herein and not defined herein shall have the meaning specified in the Note Purchase Agreement;

Whereas, all requirements of law have been fully complied with and all other acts and things necessary to make this Agreement a valid, legal and binding instrument according to its terms for the purposes herein expressed have been done or performed.

Now, therefore, upon the full and complete satisfaction of the conditions precedent to effectiveness set forth in Section 3.1 hereof, and for good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the Company and each of the Noteholders do hereby agree as follows:

	
Section 1.
	
Amendments.

	

	
Section 1.1.Sections 10.1(a)(i), (a)(ii) and (a)(iii) of the Note Purchase Agreement shall be and are hereby amended in their entirety as follows:

(a)(i) The Company will not permit the Consolidated Leverage Ratio as of the end of any fiscal quarter of the Company to exceed (A) 4.00 to 1.00 in the case of any fiscal quarter ending on or before December 31, 2019 or (B) 3.75 to 1.00 in the case of any fiscal quarter ending thereafter; and

(ii) If at the end of any fiscal quarter of the Company the Consolidated Leverage Ratio exceeded 3.75 to 1.00 (an “Adjusted Leverage Increase”), the per 

 

Stericycle, Inc.Fourth Amendment

 

annum interest rate (including any Default Rate, if applicable) otherwise applicable to each series of the Notes as specified in the first paragraph thereof shall be increased by 50 basis points (.50%) (the “Adjusted Leverage Elevated Interest Rate”) from the date of such Adjusted Leverage Increase to but not including the date that the Consolidated Leverage Ratio is 3.75 to 1.00 or less.  The Company shall promptly, and in any event within 10 Business Days after the Company’s determination of such Adjusted Leverage Increase, notify the holders of the Notes in writing of such Adjusted Leverage Increase and the date of such commencement.  Payment of the Adjusted Leverage Elevated Interest Rate shall not constitute a waiver of any Default or Event of Default hereunder; and 

(iii) If at the end of any fiscal quarter of the Company ending before or on March 31, 2020, the Unadjusted Consolidated Leverage Ratio exceeded 3.75 to 1.00, the per annum interest rate (including any Default Rate, if applicable) otherwise applicable to each series of the Notes as specified in the first paragraph thereof shall be increased as set forth below (the “Unadjusted Leverage Elevated Interest Rate”) from the date that such Unadjusted Consolidated Leverage Ratio was in excess of 3.75 to 1.00 to but not including the date that the Unadjusted Consolidated Leverage Ratio is 3.75 to 1.00 or less.  The Company shall promptly, and in any event within 10 Business Days after the Company’s determination of such increase, notify the holders of the Notes in writing and specify the date of such commencement.  Payment of the Unadjusted Leverage Elevated Interest Rate shall not constitute a waiver of any Default or Event of Default hereunder. The Unadjusted Leverage Elevated Interest Rate is determined as follows:

(A) if the Company has rating of BBB+ or better by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 50 basis points (0.50%);

(B) if the Company has rating of BBB by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 75 basis points (0.75%);

(C) if the Company has rating of BBB- by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 125 basis points (1.25%);

(D) if the Company has no rating or a rating of BB+ or worse by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 200 basis points (2.00%); and

(E) in the case where the Company has two ratings from two different Rating Agencies, the lowest such rating shall control and in the 

- 2 -

Stericycle, Inc.Fourth Amendment

 

case where the Company has three ratings from three different Rating Agencies, then the second lowest rating shall control (even if that rating is equal to that of the first lowest).

provided that, for the avoidance of doubt, the Adjusted Leverage Elevated Interest Rate and the Unadjusted Leverage Elevated Interest Rate are not cumulative with each other and only the greater of such increase under Section 10.1(a)(ii) and (iii) shall apply at any given time; and further provided that no such Increased Interest Rate will be used in calculating the Make-Whole Amount; and

Section 1.2.Section 10.4 of the Note Purchase Agreement shall be and is hereby amended in its entirety as follows:

	
 
	
Section 10.4.
	
Sales of Assets. (a) At any time on or prior to March 31, 2020, the Company will not, and will not permit any Subsidiary to, sell, lease or otherwise dispose of any assets of the Company and its Subsidiaries in a Material Sale; provided, however, that the Company or any Subsidiary may sell, lease or otherwise dispose of assets in a Material Sale if: 

	
 
	

	
(1)such assets are sold in an arms length transaction;

	
 
	

	
(2)at such time and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing; and 

	
 
	

	
(3)to the extent the net proceeds of any such Material Sale, individually or in the aggregate when combined with the net proceeds received from all other Material Sales which have occurred during the period beginning on the date of the Fourth Amendment and ending on March 31, 2020, exceeds $75,000,000, the Company offers to use the net proceeds of all such Material Sale(s) during such period to prepay or retire Senior Debt of the Company and/or its Subsidiaries no later than May 15, 2020 provided that the Company shall offer to prepay each outstanding Note in a principal amount that equals the Ratable Portion for such Note in accordance with Section 8.2 but without the payment of any Make-Whole Amount or other premium on such prepaid amount and without the requirement that any partial prepayments be in an amount not less than 10% of the original aggregate principal amount of the Notes;

As used in this Section 10.4, a “Material Sale” means any sale, lease or other disposition of assets which is not: (i) a sale or disposition of assets in the ordinary course of business of the Company and its Subsidiaries, (ii) a transfer of assets from (x) the Company to a Subsidiary Guarantor or (y) any Subsidiary to the Company or a  wholly-owned Subsidiary of the Company; provided that any transfer of assets from a Subsidiary Guarantor must be to the Company or another Subsidiary Guarantor and (iii) a sale or transfer of property acquired by the Company or any Subsidiary after the date of this Agreement to any Person within 365 days following the acquisition or construction of 

- 3 -

Stericycle, Inc.Fourth Amendment

 

such property by the Company or any Subsidiary if the Company or a Subsidiary shall concurrently with such sale or transfer, lease such property, as lessee.

(b) At any time after March 31, 2020, the Company will not, and will not permit any Subsidiary to, sell, lease or otherwise dispose of any substantial part (as defined below) of the assets of the Company and its Subsidiaries; provided, however, that the Company or any Subsidiary may sell, lease or otherwise dispose of assets constituting a substantial part of the assets of the Company and its Subsidiaries if such assets are sold in an arms length transaction and, at such time and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing and an amount equal to the net proceeds received from such sale, lease or other disposition (but only with respect to that portion of such assets that exceeds the definition of “substantial part” set forth below) shall be used within 365 days of such sale, lease or disposition, in any combination:

	
 
	

	
(1)to acquire productive assets used or useful in carrying on the business of the Company and its Subsidiaries and having a value at least equal to the value of such assets sold, leased or otherwise disposed of; and/or

	
 
	

	
(2)to prepay or retire Senior Debt of the Company and/or its Subsidiaries, provided that, to the extent any such proceeds are used to prepay the outstanding principal amount of the Notes, such prepayment shall be made in accordance with the terms of Section 8.2;  

provided further, that neither clause (1) nor clause (2) of this Section 10.4 shall be used to permit the transfer of assets from the Company to any Subsidiary.

As used in this Section 10.4, a sale, lease or other disposition of assets shall be deemed to be a “substantial part” of the assets of the Company and its Subsidiaries if the book value of such assets, when added to the book value of all other assets sold, leased or otherwise disposed of by the Company and its Subsidiaries during the period of 12 consecutive months ending on the date of such sale, lease or other disposition, exceeds 10% of the book value of Consolidated Total Assets, determined as of the end of the fiscal quarter immediately preceding such sale, lease or other disposition; provided that there shall be excluded from any determination of a “substantial part” any (i) sale or disposition of assets in the ordinary course of business of the Company and its Subsidiaries, (ii) any transfer of assets from (x) the Company to a Subsidiary Guarantor or (y) any Subsidiary to the Company or a  wholly-owned Subsidiary of the Company; provided that any transfer of assets from a Subsidiary Guarantor must be to the Company or another Subsidiary Guarantor and (iii) any sale or transfer of property acquired by the Company or any Subsidiary after the date of this Agreement to any Person within 365 days following the acquisition or construction of such property by the Company or any Subsidiary if the Company or a Subsidiary shall concurrently with such sale or transfer, lease such property, as lessee.

Section 1.3.Schedule B to the Note Purchase Agreement is hereby amended to insert the following definitions in alphabetical order:

- 4 -

Stericycle, Inc.Fourth Amendment

 

“Adjusted Leverage Increase” is defined in Section 10.1(a)(ii).

“Adjusted Leverage Elevated Interest Rate” is defined in Section 10.1(a)(ii).

“Fourth Amendment” means the Fourth Amendment dated as of December 19, 2018 to this Agreement between the Company and the holders party thereto.

“Ratable Portion” means, with respect to any Note, an amount equal to the product of (x) the amount equal to the net proceeds being so applied to the offer of prepayment of Senior Debt in accordance with Section 10.4(a), multiplied by (y) a fraction, the numerator of which is the aggregate principal amount of such Note being offered to be prepaid pursuant to Section 10.4(a) and the denominator is the aggregate principal amount of all Senior Debt of the Company and its Subsidiaries subject to an offer to be prepaid by the Company.”

“Unadjusted Leverage Elevated Interest Rate” is defined in Section 10.1(a)(iii).

	

	
Section 1.4.Schedule B to the Note Purchase Agreement is hereby amended by amending and restating each of the following definitions in its entirety to read as follows:

“Bank Credit Agreement” means the Credit Agreement dated as of November 17, 2017 by and among the Company, certain Subsidiaries of the Company named therein, Bank of America, N.A., as administrative agent, and the other financial institutions party thereto, as amended, restated, joined, supplemented or otherwise modified from time to time, and any renewals, extensions or replacements thereof, which constitute the primary bank credit facility of the Company and its Subsidiaries.

“Increased Interest Rate” means the Adjusted Leverage Elevated Interest Rate or the Unadjusted Leverage Elevated Interest Rate, as applicable.

	

	
Section 1.5.Schedule B to the Note Purchase Agreement is hereby amended by replacing clause (x) of the definition of “Consolidated EBITDA” with the following:

(x) solely for purposes of determining compliance with Section 10.1 and Section 10.2, for any fiscal quarter ending during the period from March 31, 2018 through March 31, 2020 (and for no other purposes hereunder) up to $200,000,000 in the aggregate 

- 5 -

Stericycle, Inc.Fourth Amendment

 

in any four-fiscal quarter period of cash charges incurred prior to December 31, 2019 associated with (A) implementation of the Company’s Business Transformation and Operational Optimization Expenses (each, as described in the Company’s Form 10-K for the fiscal year ended December 31, 2017), (B) internal control remediation, accounting pronouncements and related professional and consulting expenses, (C) legal and settlement related expenses and (D) up to $25,000,000 of other cash charges; provided that the amounts added back under this clause (x) for the four fiscal quarters ending March 31, 2020 shall not exceed $90,000,000 in the aggregate,

Section 1.6.Schedule B to the Note Purchase Agreement is hereby amended by deleting the definition of “Term Loan Agreement” and deleting the reference to the Term Loan Agreement in the definitions of “Consolidated EBITDA” and “Unadjusted Consolidated EBITDA”.

	
Section 2.
	
Representations and Warranties of the Company.

	

	
Section 2.1.To induce the Noteholders to execute and deliver this Agreement, the Company represents and warrants (which representations shall survive the execution and delivery of this Agreement) to the Noteholders that:

	
 
	

	
(a)this Agreement has been duly authorized, executed and delivered by the Company and, upon execution and delivery thereof by the parties hereto, this Agreement constitutes the legal, valid and binding obligation, contract and agreement of the Company enforceable against it in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws or equitable principles relating to or limiting creditors’ rights generally;

	
 
	

	
(b)the Note Purchase Agreement, as amended by this Agreement, constitutes the legal, valid and binding obligation, contract and agreement of the Company enforceable against it in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws or equitable principles relating to or limiting creditors’ rights generally;

	
 
	

	
(c)the execution, delivery and performance by the Company of this Agreement (i) has been duly authorized by all requisite corporate actions on the part of the Company, (ii) does not require the consent or approval of any governmental or regulatory body or agency, and (iii) will not (A) violate (1) any provision of law, statute, rule or regulation applicable to the Company or its certificate of incorporation or bylaws, (2) any order of any court or any rule, regulation or order of any other agency or government binding upon it, or (3) any provision of any indenture, agreement or other instrument to which it is a party or by which its properties or assets are or may be bound, or (B) result in a breach or constitute (alone or with due notice or lapse of time or both) a 

- 6 -

Stericycle, Inc.Fourth Amendment

 

	
 
		
default under any indenture, agreement or other instrument referred to in clause (iii)(A)(3) of this Section 2.1(c);

	
 
	

	
(d)as of the date hereof and after giving effect to this Agreement, no Default or Event of Default has occurred which is continuing; and

	
 
	

	
(e)the representations and warranties contained in Section 5 of the Note Purchase Agreement are true and correct in all material respects with the same force and effect as if made by the Company on and as of the date hereof, except to the extent that any such representation or warranty expressly relates to an earlier date.

	
Section 3.
	
Conditions to Effectiveness of Amendments and Waivers.

	

	
Section 3.1.The amendments to the Note Purchase Agreement set forth herein shall not become effective until, and shall become effective when (the “Effective Date”), each of the following conditions shall have been satisfied:

	
 
	

	
(a)executed counterparts of this Agreement, duly executed by the Company and the holders of 51% in principal amount of the outstanding Notes, shall have been delivered to the Noteholders;

	
 
	

	
(b)the representations and warranties of the Company set forth in Section 2 hereof shall be true and correct on and with respect to the date hereof, and the execution and delivery by the Company of this Agreement shall constitute certification by the Company of the same;

	
 
	

	
(c)the Company shall have paid a fee to each holder of Notes equal to five basis points (.05%) on the outstanding principal amount of Notes held by each such holder of a Note as of the Effective Date;

	
 
	

	
(d)the Company shall have paid the fees and expenses of Chapman and Cutler LLP, special counsel to the Noteholders, incurred in connection with the negotiation, preparation, approval, execution and delivery of this Agreement for which an invoice has been provided; 

	
 
	

	
(e)the Company shall have delivered an executed copy of an amendment to the Bank Credit Agreement amending such agreement in substance consistent with the amendments to the Note Purchase Agreement as contemplated by this Agreement, as applicable; and

	
 
	

	
(f)the Company shall have delivered executed copies of an amendment to each of the Other Note Agreements between the Company and the purchasers named therein, each amending such agreements in substance consistent with the amendments to the Note Purchase Agreement as contemplated by this Agreement.

Upon receipt and satisfaction of all of the foregoing, such amendments shall become effective.

- 7 -

Stericycle, Inc.Fourth Amendment

 

	
Section 4.
	
Miscellaneous.

	

	
Section 4.1.This Agreement shall be construed in connection with and as part of the Note Purchase Agreement, and except as modified and expressly amended by this Agreement, all terms, conditions and covenants contained in the Note Purchase Agreement are hereby ratified and confirmed and shall be and remain in full force and effect.

	

	
Section 4.2.Any and all notices, requests, certificates and other instruments, including the Notes, may refer to the “Note Purchase Agreement” or the “Note Purchase Agreement dated as of October 22, 2012” without making specific reference to this Agreement, but nevertheless all such references shall be deemed to include this Agreement unless the context shall otherwise require.

	

	
Section 4.3.The descriptive headings of the various Sections or parts of this Agreement are for convenience only and shall not affect the meaning or construction of any of the provisions hereof.

	

	
Section 4.4.This Agreement shall be governed by and construed in accordance with New York law excluding choice‐of‐law principles of the law of New York that would require the application of the laws of jurisdiction other than New York.

	

	
Section 4.5.This Agreement may be executed in any number of counterparts, each executed counterpart constituting an original, but all together only one agreement.  This Agreement, together with the Note Purchase Agreement (as amended hereby) and the Notes, constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.  Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.

 

 

[Signature Pages Follow]

- 8 -

Stericycle, Inc.Fourth Amendment

 

 

In Witness Whereof, the parties hereto have executed this Agreement as of the Effective Date.

 

Stericycle, Inc.

 

 

	
 
	
By
	
  /s/ Daniel V. Ginnetti

	
 
	

	
Name: Daniel V. Ginnetti 

	
 
	

	
Title: Executive Vice President & CFO

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

 

 

Accepted and Agreed to:

 

The Northwestern Mutual Life Insurance Company

 

By:  Northwestern Mutual Investment Management Company, LLC, its investment adviser

 

	
 
	
By
	
 /s/ David A. Barras

	
 
	

	
Name: David A. Barras

	
 
	

	
Title: Managing Director

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

The Lincoln National Life Insurance Company 

 

By:  Macquarie Investment Management Advisers, a series of Macquarie Investment Management Business Trust, Attorney-in-Fact

 

	
 
	
By
	
 

	
 
	

	
Name: 

	
 
	

	
Title: 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Voya Retirement Insurance and Annuity Company (f/k/a ING Life Insurance and Annuity Company)

By: Voya Investment Management LLC, as Agent

 

	
 
	
By
	
 /s/ Justin Stach

	
 
	

	
Name: Justin Stach

	
 
	

	
Title: Vice President

 

 

NN Life Insurance Company Ltd. 

 

By:  Voya Investment Management LLC, as Attorney in fact

 

	
 
	
By
	
 /s/ Justin Stach

	
 
	

	
Name: Justin Stach

	
 
	

	
Title: Vice President

 

 

Voya Insurance and Annuity Company (f/k/a ING USA Annuity and Life Insurance Company)

By: Voya Investment Management Co. LLC, as Agent

 

	
 
	
By
	
 /s/ Justin Stach

	
 
	

	
Name: Justin Stach

	
 
	

	
Title: Vice President

 

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Voya Insurance and Annuity Company (f/k/a IG USA Annuity and Life Insurance Company)

 

By: Athene Asset Management LLC, as investment adviser

 

	
 
	
By
	
 /s/ Roger D. Fors

	
 
	

	
Name: Roger D. Fors

	
 
	

	
Title: Senior Vice President, Fixed Income

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Principal Life Insurance Company 

 

By: Principal Global Investors, LLC

a Delaware limited liability company, its authorized signatory

 

	
 
	
By
	
 /s/ Alex P. Montz

	
 
	

	
Name: Alex P. Montz, Counsel

	
 
	

	
Title: 

 

	
 
	
By
	
 /s/ Justin T. Lange

	
 
	

	
Name: Justin T. Lange, Counsel

	
 
	

	
Title: 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Symetra Life Insurance Company 

By MetLife Investment Advisors, LLC, Its Investment Manager

 

	
 
	
By
	
 /s/ Frank O. Monfalcone

	
 
	

	
Name: Frank O. Monfalcone 

	
 
	

	
Title: Managing Director

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Penn Mutual Life Insurance Company 

 

 

	
 
	
By
	
 

	
 
	

	
Name: 

	
 
	

	
Title: 

 

	
 
	
By
	
 

	
 
	

	
Name: 

	
 
	

	
Title: 

 

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Jackson National Life Insurance Company

 

By:  PPM America, Inc., as attorney in fact on behalf of Jackson National Life Insurance Company

 

	
 
	
By
	
 /s/ Elena Unger

	
 
	

	
Name: Elena Unger

	
 
	

	
Title: Vice President

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Thrivent Financial for Lutherans

 

	
 
	
By
	
 /s/ Christopher Patton

	
 
	

	
Name: Christopher Patton

	
 
	

	
Title: Managing Director

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

MONY LIFE INSURANCE COMPANY 

 

 

	
 
	
By
	
 

	
 
	

	
Name: 

	
 
	

	
Title: 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

AXA Equitable Life Insurance Company 

 

	
 
	
By
	
 /s/ Amy Judd

	
 
	

	
Name: Amy Judd

	
 
	

	
Title: Investment Officer

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

RiverSource Life Insurance Company 

 

	
 
	
By
	
 /s/ Thomas W. Murphy

	
 
	

	
Name: Thomas W. Murphy

	
 
	

	
Title: Vice President – Investments

 

RiverSource Life Insurance Co. Of New York

 

	
 
	
By
	
 /s/ Thomas W. Murphy

	
 
	

	
Name: Thomas W. Murphy

	
 
	

	
Title: Vice President – Investments

 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Western-Southern Life Assurance Company 

 

	
 
	
By
	
 /s/ Daniel R. Larsen

	
 
	

	
Name: Daniel R. Larsen 

	
 
	

	
Title: Vice President 

 

	
 
	
By
	
 /s/ Kevin L. Howard

	
 
	

	
Name: Kevin L. Howard

	
 
	

	
Title: Vice President 

 

 

Columbus Life Insurance Company 

 

	
 
	
By
	
 /s/ Daniel R. Larsen

	
 
	

	
Name: Daniel R. Larsen 

	
 
	

	
Title: Vice President 

 

	
 
	
By
	
 /s/ Kevin L. Howard

	
 
	

	
Name: Kevin L. Howard

	
 
	

	
Title: Vice President 

 

Integrity Life Insurance Company 

 

	
 
	
By
	
 /s/ Daniel R. Larsen

	
 
	

	
Name: Daniel R. Larsen 

	
 
	

	
Title: Vice President 

 

	
 
	
By
	
 /s/ Kevin L. Howard

	
 
	

	
Name: Kevin L. Howard

	
 
	

	
Title: Senior Vice President 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Integrity Life Insurance Company Separate Account GPO

 

	
 
	
By
	
 /s/ Daniel R. Larsen

	
 
	

	
Name: Daniel R. Larsen 

	
 
	

	
Title: Vice President 

 

	
 
	
By
	
 /s/ Kevin L. Howard

	
 
	

	
Name: Kevin L. Howard

	
 
	

	
Title: Senior Vice President 

 

 

National Integrity Life Insurance Company Separate Account GPO

 

	
 
	
By
	
 /s/ Daniel R. Larsen

	
 
	

	
Name: Daniel R. Larsen 

	
 
	

	
Title: Vice President 

 

	
 
	
By
	
 /s/ Kevin L. Howard

	
 
	

	
Name: Kevin L. Howard

	
 
	

	
Title: Vice President 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Great-West Life & Annuity Insurance Company

 

	
 
	
By
	
 /s/ Ward Argust

	
 
	

	
Name: Ward Argust

	
 
	

	
Title: Assistant Vice President, Investments 

 

 

Great-West Life & Annuity Insurance Company of South Carolina 

 

	
 
	
By
	
 /s/ Ward Argust

	
 
	

	
Name: Ward Argust

	
 
	

	
Title: Authorized Signatory  

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Commonwealth Annuity and Life Insurance Company

 

By:  Hartford Investment Management Company its investment manager

 

	
 
	
By
	
 /s/ Kenneth W. Day

	
 
	

	
Name: Kenneth W. Day 

	
 
	

	
Title: Vice President

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

The Guardian Life Insurance Company of America

 

 

	
 
	
By
	
 /s/ Brian Keating 

	
 
	

	
Name: Brian Keating 

	
 
	

	
Title: Managing Director

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Modern Woodmen of America

 

	
 
	
By
	
 /s/ Aaron R. Birkland

	
 
	

	
Name: Aaron R. Birkland

	
 
	

	
Title: Portfolio Manager, Private Placements

 

	
 
	
By
	
 /s/ Christopher M. Cramer

	
 
	

	
Name: Christopher M. Cramer

	
 
	

	
Title: Manager, Fixed Income

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

Trinity Universal Insurance Company 

Catholic United Financial 

Occidental Life Insurance Company of North Carolina 

Western Fraternal Life Association

 

By: Securian Asset Management, Inc. 

 

 

	
 
	
By
	
 /s/ Drew R. Smith

	
 
	

	
Name: Drew R. Smith

	
 
	

	
Title: Vice President 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Southern Farm Bureau Life Insurance Company

 

	
 
	
By
	
 /s/ David Divine

	
 
	

	
Name: David Divine

	
 
	

	
Title: Senior Portfolio Manager

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Woodmen of the World Life Insurance Society

 

	
 
	
By
	
 /s/ Shawn Bengtson

	
 
	

	
Name: Shawn Bengtson

	
 
	

	
Title: Vice-President, Investment

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

American United Life Insurance Company 

 

	
 
	
By
	
 /s/ Mike Bullock 

	
 
	

	
Name: Mike Bullock 

	
 
	

	
Title: VP, Private Placements 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

 

Accepted and Agreed to:

 

 

AMERITAS LIFE INSURANCE CORP. SUCCESOR BY MERGER TO ACACIA LIFE INSURANCE COMPANY

 

AMERITAS LIFE INSURANCE CORP. SUCCESSOR BY MERGER TO THE UNION CENTRAL LIFE INSURANCE COMPANY

 

AMERITAS LIFE INSURANCE CORP. OF NEW YORK

 

By; Ameritas Investment Partners, Inc., as Agent

 

	
 
	
By
	
 /s/ Tina Udell

	
 
	

	
Name: Tina Udell 

	
 
	

	
Title: Vice President & Managing Director

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

USAA Life Insurance Company 

 

	
 
	
By
	
 /s/ James F. Jackson, Jr. 

	
 
	

	
Name: James F. Jackson, Jr. 

	
 
	

	
Title: Assistant Vice President  

 

United Services Automobile Association 

 

	
 
	
By
	
 /s/ James F. Jackson, Jr. 

	
 
	

	
Name: James F. Jackson, Jr. 

	
 
	

	
Title: Assistant Vice President  

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

Country Life Insurance Company

 

	
 
	
By
	
 /s/ John Jacobs

	
 
	

	
Name: John Jacobs

	
 
	

	
Title: Director – Fixed Income

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

Accepted and Agreed to:

 

 

ProAssurance Casualty Company 

ProAssurance Indemnity Company, Inc. 

 

By: Prime Advisors, Inc., its Attorney-in-Fact

 

	
 
	
By
	
 /s/ Naomi Urata Joy 

	
 
	

	
Name: Naomi Urata Joy 

	
 
	

	
Title: Vice President 

 

 

 

Stericycle, Inc.Fourth Amendment

 

 

 

Accepted and Agreed to:

 

 

State of Wisconsin Investment Board 

 

	
 
	
By
	
 /s/ Christopher P. Prestigiacomo  

	
 
	

	
Name: Christopher P. Prestigiacomo 

	
 
	

	
Title: Portfolio Managersrcl-ex104_103.htm

Exhibit 10.4

 

 

 

 

Stericycle, Inc.

___________________________________

Fifth Amendment

Dated as of December 19, 2018

to

Note Purchase Agreement

Dated as of April 30, 2015

___________________________________

 

Re:2.72% Senior Notes, Series A, due July 1, 2022

and

2.79% Senior Notes, Series B, due July 1, 2023

 

 

 

 

4280616

 

Fifth Amendment to Note Purchase Agreement

This Fifth Amendment dated as of December 19, 2018 (this “Agreement”) to the Note Purchase Agreement referred to below is between Stericycle, Inc., a Delaware corporation (the “Company”), and each of the institutions which is a signatory to this Agreement (collectively, the “Noteholders”).

Recitals:

Whereas, the Company and each of the Noteholders have heretofore entered into the Note Purchase Agreement dated as of April 30, 2015, as amended by that certain First Amendment thereto dated as of June 30, 2015, that certain Second Amendment thereto dated as of August 30, 2015, that certain Third Amendment thereto dated as of July 28, 2017 and that certain Fourth Amendment thereto dated as of March 23, 2018 (as so amended, the “Note Purchase Agreement”), pursuant to which the Company issued on or about July 1, 2015 (a) $250,000,000 aggregate principal amount of its 2.72% Senior Notes, Series A, due July 1, 2022 (as amended, the “Series A Notes”) and (b) $100,000,000 aggregate principal amount of its 2.79% Senior Notes, Series B, due July 1, 2023 (as amended, the “Series B Notes” and together with the Series A Notes, collectively, the “Notes”);

Whereas, the Company and the Noteholders now desire to amend the Note Purchase Agreement and the Notes in the respects, but only in the respects, hereinafter set forth;

Whereas, all capitalized terms used herein and not defined herein shall have the meaning specified in the Note Purchase Agreement;

Whereas, all requirements of law have been fully complied with and all other acts and things necessary to make this Agreement a valid, legal and binding instrument according to its terms for the purposes herein expressed have been done or performed.

Now, therefore, upon the full and complete satisfaction of the conditions precedent to effectiveness set forth in Section 3.1 hereof, and for good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the Company and each of the Noteholders do hereby agree as follows:

	
Section 1.
	
Amendments.

	

	
Section 1.1.Sections 10.1(a)(i), (a)(ii) and (a)(iii) of the Note Purchase Agreement shall be and are hereby amended in their entirety as follows:

(a)(i) The Company will not permit the Consolidated Leverage Ratio as of the end of any fiscal quarter of the Company to exceed (A) 4.00 to 1.00 in the case of any fiscal quarter ending on or before December 31, 2019 or (B) 3.75 to 1.00 in the case of any fiscal quarter ending thereafter; and

 

Stericycle, Inc.Fifth Amendment

 

(ii) If at the end of any fiscal quarter of the Company the Consolidated Leverage Ratio exceeded 3.75 to 1.00 (an “Adjusted Leverage Increase”), the per annum interest rate (including any Default Rate, if applicable) otherwise applicable to each series of the Notes as specified in the first paragraph thereof shall be increased by 50 basis points (.50%) (the “Adjusted Leverage Elevated Interest Rate”) from the date of such Adjusted Leverage Increase to but not including the date that the Consolidated Leverage Ratio is 3.75 to 1.00 or less.  The Company shall promptly, and in any event within 10 Business Days after the Company’s determination of such Adjusted Leverage Increase, notify the holders of the Notes in writing of such Adjusted Leverage Increase and the date of such commencement.  Payment of the Adjusted Leverage Elevated Interest Rate shall not constitute a waiver of any Default or Event of Default hereunder; and 

(iii) If at the end of any fiscal quarter of the Company ending before or on March 31, 2020, the Unadjusted Consolidated Leverage Ratio exceeded 3.75 to 1.00, the per annum interest rate (including any Default Rate, if applicable) otherwise applicable to each series of the Notes as specified in the first paragraph thereof shall be increased as set forth below (the “Unadjusted Leverage Elevated Interest Rate”) from the date that such Unadjusted Consolidated Leverage Ratio was in excess of 3.75 to 1.00 to but not including the date that the Unadjusted Consolidated Leverage Ratio is 3.75 to 1.00 or less.  The Company shall promptly, and in any event within 10 Business Days after the Company’s determination of such increase, notify the holders of the Notes in writing and specify the date of such commencement.  Payment of the Unadjusted Leverage Elevated Interest Rate shall not constitute a waiver of any Default or Event of Default hereunder. The Unadjusted Leverage Elevated Interest Rate is determined as follows:

(A) if the Company has rating of BBB+ or better by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 50 basis points (0.50%);

(B) if the Company has rating of BBB by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 75 basis points (0.75%);

(C) if the Company has rating of BBB- by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 125 basis points (1.25%);

(D) if the Company has no rating or a rating of BB+ or worse by S&P or the equivalent rating by any other Rating Agency, then the Unadjusted Leverage Elevated Interest Rate shall be an additional 200 basis points (2.00%); and

- 2 -

Stericycle, Inc.Fifth Amendment

 

(E) in the case where the Company has two ratings from two different Rating Agencies, the lowest such rating shall control and in the case where the Company has three ratings from three different Rating Agencies, then the second lowest rating shall control (even if that rating is equal to that of the first lowest).

provided that, for the avoidance of doubt, the Adjusted Leverage Elevated Interest Rate and the Unadjusted Leverage Elevated Interest Rate are not cumulative with each other and only the greater of such increase under Section 10.1(a)(ii) and (iii) shall apply at any given time; and further provided that no such Increased Interest Rate will be used in calculating the Make-Whole Amount; and

Section 1.2.Section 10.4 of the Note Purchase Agreement shall be and is hereby amended in its entirety as follows:

	
 
	
Section 10.4.
	
Sales of Assets. (a) At any time on or prior to March 31, 2020, the Company will not, and will not permit any Subsidiary to, sell, lease or otherwise dispose of any assets of the Company and its Subsidiaries in a Material Sale; provided, however, that the Company or any Subsidiary may sell, lease or otherwise dispose of assets in a Material Sale if: 

	
 
	

	
(1)such assets are sold in an arms length transaction;

	
 
	

	
(2)at such time and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing; and 

	
 
	

	
(3)to the extent the net proceeds of any such Material Sale, individually or in the aggregate when combined with the net proceeds received from all other Material Sales which have occurred during the period beginning on the date of the Fourth Amendment and ending on March 31, 2020, exceeds $75,000,000, the Company offers to use the net proceeds of all such Material Sale(s) during such period to prepay or retire Senior Debt of the Company and/or its Subsidiaries no later than May 15, 2020 provided that the Company shall offer to prepay each outstanding Note in a principal amount that equals the Ratable Portion for such Note in accordance with Section 8.2 but without the payment of any Make-Whole Amount or other premium on such prepaid amount and without the requirement that any partial prepayments be in an amount not less than 10% of the original aggregate principal amount of the Notes;

As used in this Section 10.4, a “Material Sale” means any sale, lease or other disposition of assets which is not: (i) a sale or disposition of assets in the ordinary course of business of the Company and its Subsidiaries, (ii) a transfer of assets from (x) the Company to a Subsidiary Guarantor or (y) any Subsidiary to the Company or a  wholly-owned Subsidiary of the Company; provided that any transfer of assets from a Subsidiary Guarantor must be to the Company or another Subsidiary Guarantor and (iii) a sale or transfer of property acquired by the Company or any Subsidiary after the date of this 

- 3 -

Stericycle, Inc.Fifth Amendment

 

Agreement to any Person within 365 days following the acquisition or construction of such property by the Company or any Subsidiary if the Company or a Subsidiary shall concurrently with such sale or transfer, lease such property, as lessee.

(b) At any time after March 31, 2020, the Company will not, and will not permit any Subsidiary to, sell, lease or otherwise dispose of any substantial part (as defined below) of the assets of the Company and its Subsidiaries; provided, however, that the Company or any Subsidiary may sell, lease or otherwise dispose of assets constituting a substantial part of the assets of the Company and its Subsidiaries if such assets are sold in an arms length transaction and, at such time and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing and an amount equal to the net proceeds received from such sale, lease or other disposition (but only with respect to that portion of such assets that exceeds the definition of “substantial part” set forth below) shall be used within 365 days of such sale, lease or disposition, in any combination:

	
 
	

	
(1)to acquire productive assets used or useful in carrying on the business of the Company and its Subsidiaries and having a value at least equal to the value of such assets sold, leased or otherwise disposed of; and/or

	
 
	

	
(2)to prepay or retire Senior Debt of the Company and/or its Subsidiaries, provided that, to the extent any such proceeds are used to prepay the outstanding principal amount of the Notes, such prepayment shall be made in accordance with the terms of Section 8.2;  

provided further, that neither clause (1) nor clause (2) of this Section 10.4 shall be used to permit the transfer of assets from the Company to any Subsidiary.

As used in this Section 10.4, a sale, lease or other disposition of assets shall be deemed to be a “substantial part” of the assets of the Company and its Subsidiaries if the book value of such assets, when added to the book value of all other assets sold, leased or otherwise disposed of by the Company and its Subsidiaries during the period of 12 consecutive months ending on the date of such sale, lease or other disposition, exceeds 10% of the book value of Consolidated Total Assets, determined as of the end of the fiscal quarter immediately preceding such sale, lease or other disposition; provided that there shall be excluded from any determination of a “substantial part” any (i) sale or disposition of assets in the ordinary course of business of the Company and its Subsidiaries, (ii) any transfer of assets from (x) the Company to a Subsidiary Guarantor or (y) any Subsidiary to the Company or a  wholly-owned Subsidiary of the Company; provided that any transfer of assets from a Subsidiary Guarantor must be to the Company or another Subsidiary Guarantor and (iii) any sale or transfer of property acquired by the Company or any Subsidiary after the date of this Agreement to any Person within 365 days following the acquisition or construction of such property by the Company or any Subsidiary if the Company or a Subsidiary shall concurrently with such sale or transfer, lease such property, as lessee.

- 4 -

Stericycle, Inc.Fifth Amendment

 

Section 1.3.Schedule B to the Note Purchase Agreement is hereby amended to insert the following definitions in alphabetical order:

“Adjusted Leverage Increase” is defined in Section 10.1(a)(ii).

“Adjusted Leverage Elevated Interest Rate” is defined in Section 10.1(a)(ii).

“Fifth Amendment” means the Fifth Amendment dated as of December 19, 2018 to this Agreement between the Company and the holders party thereto.

“Ratable Portion” means, with respect to any Note, an amount equal to the product of (x) the amount equal to the net proceeds being so applied to the offer of prepayment of Senior Debt in accordance with Section 10.4(a), multiplied by (y) a fraction, the numerator of which is the aggregate principal amount of such Note being offered to be prepaid pursuant to Section 10.4(a) and the denominator is the aggregate principal amount of all Senior Debt of the Company and its Subsidiaries subject to an offer to be prepaid by the Company.”

“Unadjusted Leverage Elevated Interest Rate” is defined in Section 10.1(a)(iii).

	

	
Section 1.4.Schedule B to the Note Purchase Agreement is hereby amended by amending and restating each of the following definitions in its entirety to read as follows:

“Bank Credit Agreement” means the Credit Agreement dated as of November 17, 2017 by and among the Company, certain Subsidiaries of the Company named therein, Bank of America, N.A., as administrative agent, and the other financial institutions party thereto, as amended, restated, joined, supplemented or otherwise modified from time to time, and any renewals, extensions or replacements thereof, which constitute the primary bank credit facility of the Company and its Subsidiaries.

“Increased Interest Rate” means the Adjusted Leverage Elevated Interest Rate or the Unadjusted Leverage Elevated Interest Rate, as applicable.

	

	
Section 1.5.Schedule B to the Note Purchase Agreement is hereby amended by replacing clause (x) of the definition of “Consolidated EBITDA” with the following:

- 5 -

Stericycle, Inc.Fifth Amendment

 

(x) solely for purposes of determining compliance with Section 10.1 and Section 10.2, for any fiscal quarter ending during the period from March 31, 2018 through March 31, 2020 (and for no other purposes hereunder) up to $200,000,000 in the aggregate in any four-fiscal quarter period of cash charges incurred prior to December 31, 2019 associated with (A) implementation of the Company’s Business Transformation and Operational Optimization Expenses (each, as described in the Company’s Form 10-K for the fiscal year ended December 31, 2017), (B) internal control remediation, accounting pronouncements and related professional and consulting expenses, (C) legal and settlement related expenses and (D) up to $25,000,000 of other cash charges; provided that the amounts added back under this clause (x) for the four fiscal quarters ending March 31, 2020 shall not exceed $90,000,000 in the aggregate,

Section 1.6.Schedule B to the Note Purchase Agreement is hereby amended by deleting the definition of “Term Loan Agreement” and deleting the reference to the Term Loan Agreement in the definitions of “Consolidated EBITDA” and “Unadjusted Consolidated EBITDA”.

	
Section 2.
	
Representations and Warranties of the Company.

	

	
Section 2.1.To induce the Noteholders to execute and deliver this Agreement, the Company represents and warrants (which representations shall survive the execution and delivery of this Agreement) to the Noteholders that:

	
 
	

	
(a)this Agreement has been duly authorized, executed and delivered by the Company and, upon execution and delivery thereof by the parties hereto, this Agreement constitutes the legal, valid and binding obligation, contract and agreement of the Company enforceable against it in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws or equitable principles relating to or limiting creditors’ rights generally;

	
 
	

	
(b)the Note Purchase Agreement, as amended by this Agreement, constitutes the legal, valid and binding obligation, contract and agreement of the Company enforceable against it in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws or equitable principles relating to or limiting creditors’ rights generally;

	
 
	

	
(c)the execution, delivery and performance by the Company of this Agreement (i) has been duly authorized by all requisite corporate actions on the part of the Company, (ii) does not require the consent or approval of any governmental or regulatory body or agency, and (iii) will not (A) violate (1) any provision of law, statute, rule or regulation applicable to the Company or its certificate of incorporation or bylaws, (2) any order of any court or any rule, regulation or order of any other agency or 

- 6 -

Stericycle, Inc.Fifth Amendment

 

	
 
		
government binding upon it, or (3) any provision of any indenture, agreement or other instrument to which it is a party or by which its properties or assets are or may be bound, or (B) result in a breach or constitute (alone or with due notice or lapse of time or both) a default under any indenture, agreement or other instrument referred to in clause (iii)(A)(3) of this Section 2.1(c);

	
 
	

	
(d)as of the date hereof and after giving effect to this Agreement, no Default or Event of Default has occurred which is continuing; and

	
 
	

	
(e)the representations and warranties contained in Section 5 of the Note Purchase Agreement are true and correct in all material respects with the same force and effect as if made by the Company on and as of the date hereof, except to the extent that any such representation or warranty expressly relates to an earlier date.

	
Section 3.
	
Conditions to Effectiveness of Amendments and Waivers.

	

	
Section 3.1.The amendments to the Note Purchase Agreement set forth herein shall not become effective until, and shall become effective when (the “Effective Date”), each of the following conditions shall have been satisfied:

	
 
	

	
(a)executed counterparts of this Agreement, duly executed by the Company and the holders of 51% in principal amount of the outstanding Notes, shall have been delivered to the Noteholders;

	
 
	

	
(b)the representations and warranties of the Company set forth in Section 2 hereof shall be true and correct on and with respect to the date hereof, and the execution and delivery by the Company of this Agreement shall constitute certification by the Company of the same;

	
 
	

	
(c)the Company shall have paid a fee to each holder of Notes equal to five basis points (.05%) on the outstanding principal amount of Notes held by each such holder of a Note as of the Effective Date;

	
 
	

	
(d)the Company shall have paid the fees and expenses of Chapman and Cutler LLP, special counsel to the Noteholders, incurred in connection with the negotiation, preparation, approval, execution and delivery of this Agreement for which an invoice has been provided; 

	
 
	

	
(e)the Company shall have delivered an executed copy of an amendment to the Bank Credit Agreement amending such agreement in substance consistent with the amendments to the Note Purchase Agreement as contemplated by this Agreement, as applicable; and

	
 
	

	
(f)the Company shall have delivered executed copies of an amendment to each of the Other Note Agreements between the Company and the purchasers named 

- 7 -

Stericycle, Inc.Fifth Amendment

 

	
 
		
therein, each amending such agreements in substance consistent with the amendments to the Note Purchase Agreement as contemplated by this Agreement.

Upon receipt and satisfaction of all of the foregoing, such amendments shall become effective.

	
Section 4.
	
Miscellaneous.

	

	
Section 4.1.This Agreement shall be construed in connection with and as part of the Note Purchase Agreement, and except as modified and expressly amended by this Agreement, all terms, conditions and covenants contained in the Note Purchase Agreement are hereby ratified and confirmed and shall be and remain in full force and effect.

	

	
Section 4.2.Any and all notices, requests, certificates and other instruments, including the Notes, may refer to the “Note Purchase Agreement” or the “Note Purchase Agreement dated as of April 30, 2015” without making specific reference to this Agreement, but nevertheless all such references shall be deemed to include this Agreement unless the context shall otherwise require.

	

	
Section 4.3.The descriptive headings of the various Sections or parts of this Agreement are for convenience only and shall not affect the meaning or construction of any of the provisions hereof.

	

	
Section 4.4.This Agreement shall be governed by and construed in accordance with New York law excluding choice‐of‐law principles of the law of New York that would require the application of the laws of jurisdiction other than New York.

	

	
Section 4.5.This Agreement may be executed in any number of counterparts, each executed counterpart constituting an original, but all together only one agreement.  This Agreement, together with the Note Purchase Agreement (as amended hereby) and the Notes, constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.  Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.

 

 

[Signature Pages Follow]

- 8 -

Stericycle, Inc.Fifth Amendment

 

 

In Witness Whereof, the parties hereto have executed this Agreement as of the Effective Date.

 

Stericycle, Inc.

 

 

	
 
	
By
	
 /s/ Daniel V. Ginnetti

	
 
	

	
Name: Daniel V. Ginnetti 

	
 
	

	
Title: Executive Vice President & CFO

 

 

 

 

Stericycle, Inc.Fifth Amendment

 

 

 

Accepted and Agreed to:

 

 

New York Life Insurance Company

 

	
 
	
By
	
 /s/ Clara Fagan

	
 
	

	
Name: Clara Fagan 

	
 
	

	
Title: Corporate Vice President

 

 

New York Life Insurance and Annuity Corporation

 

By NYL Investors LLC, Its Investment Manager

 

	
 
	
By
	
 /s/ Clara Fagan

	
 
	

	
Name: Clara Fagan 

	
 
	

	
Title: Director

 

 

New York Life Insurance and Annuity Corporation Institutionally Owned Life Insurance Separate Account (BOLI 3-2)

 

By NYL Investors LLC, Its Investment Manager

 

	
 
	
By
	
 /s/ Clara Fagan

	
 
	

	
Name: Clara Fagan 

	
 
	

	
Title: Director

 

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

The Northwestern Mutual Life Insurance Company

 

By:  Northwestern Mutual Investment Management Company, LLC, its investment adviser

 

	
 
	
By
	
 /s/ David A. Barras

	
 
	

	
Name: David A. Barras

	
 
	

	
Title: Managing Director

 

The Northwestern Mutual Life Insurance Company for its Group Annuity Separate Account

 

 

	
 
	
By
	
 /s/ David A. Barras

	
 
	

	
Name: David A. Barras

	
 
	

	
Title: Its Authorized Representative

 

 

 

Stericycle, Inc.Fifth Amendment

 

 

Accepted and Agreed to:

 

 

STATE FARM LIFE INSURANCE 

 

 

	
 
	
By
	
 /s/ Julie Hoyer

	
 
	

	
Name: Julie Hoyer

	
 
	

	
Title: Investment Executive 

 

 

	
 
	
By
	
 /s/ Jeffrey Attwood

	
 
	

	
Name: Jeffrey Attwood

	
 
	

	
Title: Investment Professional

 

 

STATE FARM LIFE And Accident Assurance Company 

 

 

	
 
	
By
	
 /s/ Julie Hoyer

	
 
	

	
Name: Julie Hoyer

	
 
	

	
Title: Investment Executive 

 

 

	
 
	
By
	
 /s/ Jeffrey Attwood

	
 
	

	
Name: Jeffrey Attwood

	
 
	

	
Title: Investment Professional

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

Thrivent Financial for Lutherans

 

	
 
	
By
	
 /s/ Christopher Patton

	
 
	

	
Name: Christopher Patton

	
 
	

	
Title: Managing Director

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

AXA Equitable Life Insurance Company 

 

	
 
	
By
	
 /s/ Amy Judd

	
 
	

	
Name: Amy Judd

	
 
	

	
Title: Investment Officer

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

Great-West Life & Annuity Insurance Company

 

	
 
	
By
	
 /s/ Ward Argust

	
 
	

	
Name: Ward Argust

	
 
	

	
Title: Assistant Vice President, Investments 

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

The Guardian Life Insurance Company of America

 

	
 
	
By
	
 /s/ Brian Keating 

	
 
	

	
Name: Brian Keating 

	
 
	

	
Title: Managing Director

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

Metropolitan Life Insurance Company

by MetLife Investment Advisors, LLC, Its Investment Manager

 

Metropolitan Tower Life Insurance Company

f/k/a General American Life Insurance Company

by MetLife Investment Advisors, LLC, Its Investment Manager

 

Metropolitan Insurance K.K.

by MetLife Investment Advisors, LLC, Its Investment Manager

 

	
 
	
By
	
 /s/ John Wills

	
 
	

	
Name: John Wills 

	
 
	

	
Title: Managing Director

 

 

Brighthouse Life Insurance Company

by MetLife Investment Advisors, LLC, Its Investment Manager

 

 

Brighthouse Life Insurance Company of NY

by MetLife Investment Advisors, LLC, Its Investment Manager

 

 

	
 
	
By
	
 /s/ Frank O. Monfalcone

	
 
	

	
Name: Frank O. Monfalcone

	
 
	

	
Title: Managing Director

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

Nationwide Life Insurance Company

 

 

	
 
	
By
	
 /s/ Jason M. Comisar

	
 
	

	
Name: Jason M. Comisar

	
 
	

	
Title: Authorized Signatory

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

RiverSource Life Insurance Company 

 

 

	
 
	
By
	
 /s/ Thomas W. Murphy

	
 
	

	
Name: Thomas W. Murphy

	
 
	

	
Title: Vice President - Investments

 

RiverSource Life Insurance Company of New York  

 

 

	
 
	
By
	
 /s/ Thomas W. Murphy

	
 
	

	
Name: Thomas W. Murphy

	
 
	

	
Title: Vice President - Investments

 

 

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

 

State of Wisconsin Investment Board 

 

	
 
	
By
	
 /s/ Christopher P. Prestigiacomo  

	
 
	

	
Name: Christopher P. Prestigiacomo 

	
 
	

	
Title: Portfolio Manager

 

 

Stericycle, Inc.Fifth Amendment

 

Accepted and Agreed to:

 

Catholic United Financial 

GuideOne Mutual Insurance Company 

GuideOne Property & Casualty Insurance Company

 

By: Securian Asset Management, Inc. 

 

 

	
 
	
By
	
 /s/ Drew R. Smith

	
 
	

	
Name: Drew R. Smith

	
 
	

	
Title: Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]